반응식
[CH3:1][C:2]1[CH:3]=[CH:4][CH:5]=[CH:6][C:7]=1[C:8]([NH:10][C:11]1[CH:12]=[CH:13][C:14]([C:18]([N:20]2[C:26]3[CH:27]=[CH:28][C:29]([Cl:31])=[CH:30][C:25]=3[CH:24]([OH:32])[CH2:23][CH2:22][CH2:21]2)=[O:19])=[C:15]([CH3:17])[CH:16]=1)=[O:9].N1C=CC=CC=1.[Cl:39][CH2:40][CH2:41][CH2:42][C:43](Cl)=[O:44].O>ClCCl>[Cl:39][CH2:40][CH2:41][CH2:42][C:43]([O:32][CH:24]1[CH2:23][CH2:22][CH2:21][N:20]([C:18](=[O:19])[C:14]2[CH:13]=[CH:12][C:11]([NH:10][C:8](=[O:9])[C:7]3[CH:6]=[CH:5][CH:4]=[CH:3][C:2]=3[CH3:1])=[CH:16][C:15]=2[CH3:17])[C:26]2[CH:27]=[CH:28][C:29]([Cl:31])=[CH:30][C:25]1=2)=[O:44]참가 물질
실험 절차
Tolvaptan (10.0 g, 22.3 mmol) was dispersed in dichloromethane (100 ml). Pyridine (2.7 ml) was added thereto, and the mixture was stirred. 4-Chlorobutyric acid chloride (3.74 ml) was gradually added to the obtained mixture, and the mixture was stirred at room temperature over night. The reactant was then poured into water, and the mixture was extracted with dichloromethane, washed with a sodium hydrogen sulfate aqueous solution, dried over magnesium sulfate. After filtration and concentration under reduced pressure, the resulted residue was crystallized with diethyl ether. The resulted crystals were collected by filtration, and dried to obtain 10.7 g of 7-chloro-1-[2-methyl-4-(2-methylbenzamido)benzoyl]-2,3,4,5-tetrahydro-1H-benzo[b]azepin-5-yl 4-chlorobutyrate as white powder.
후처리
- stirringthe mixture was stirred at room temperature over night
- extractionthe mixture was extracted with dichloromethane
- washwashed with a sodium hydrogen sulfate aqueous solution
- dry with materialdried over magnesium sulfate
- filtrationAfter filtration and concentration under reduced pressure
- customthe resulted residue was crystallized with diethyl ether
- filtrationThe resulted crystals were collected by filtration
- customdried
출처 및 근거
- ORD 기록
- ord-082eedab464b4964a3a154191056b482
- 출처 데이터셋
- uspto-grants-2014_03
- 특허 번호
- US08669229B2
연결된 노트
불러오는 중…